Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07231900
PHASE2/PHASE3
Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients
Sponsor: Assaf-Harofeh Medical Center
View on ClinicalTrials.gov
Summary
The study is designed to diminish intra-dialytic hypertension in chrnic hemodialysis patients suffering from metabolic acidosis (low bicarbonate levels). The intervention is a tab of 500 mg sodium bicarbonate twice a day for one month, vs. placebo.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-11-10
Completion Date
2027-12-01
Last Updated
2025-11-17
Healthy Volunteers
No
Conditions
Interventions
DRUG
Sodium Bicarbonate (NaHCO3)
Prescribing Sodium Bicaronate for intra-dualytic hypertension
DRUG
Placebo
1 tab X 2/day
Locations (1)
Shamir medical center
Ẕerifin, Is, Israel